Identification of annexin II as a novel secretory biomarker for breast cancer

Proteomics

Volumn 13, Issue 21, 2013, Pages 3145-3156

  Jeon, You Rim ^a   Kim, Sun Young ^a   Lee, Eun Jeong ^b   Kim, Yong Nyun ^b   Noh, Dong Young ^c   Park, So Yeon ^d   Moon, Aree ^a  

^a Duksung Women's University   (South Korea)

^b National Cancer Center   (South Korea)

^c Seoul National University   (South Korea)

^d Seoul National University Bundang Hospital   (South Korea)

Author keywords

Annexin II; Biomarker; Cell biology; H Ras; Invasion; Secretome

Indexed keywords

LIPOCORTIN 2;

ACTIN FILAMENT; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER PATIENT; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; ONCOGENE H RAS; ONCOGENE N RAS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANNEXIN II; BIOMARKER; CELL BIOLOGY; H-RAS; INVASION; SECRETOME;

ANNEXIN A2; BREAST; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; IMMUNOBLOTTING; NEOPLASM INVASIVENESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEINS; PROTEOMICS; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 84887035043     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201300127     Document Type: Article

References (56)

1. Jemal, A., Siegel, R., Ward, E., Hao, Y. et al., Cancer statistics. CA Cancer J. Clin. 2009, 59, 225-449.
2. Sotiriou, C., Neo, S. Y., McShane, L. M., Korn, E. L. et al., Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc. Natl. Acad. Sci. U S A 2003, 100, 10393-10398.
3. Cho, W. C., Cheng, C. H., Oncoproteomics: current trends and future perspectives. Expert Rev. Proteomics 2007, 4, 401-410.
4. Simpson, R. J., Bernhard, O. K., Greening, D. W., Moritz, R. L., Proteomics-driven cancer biomarker discovery: looking to the future. Curr. Opin. Chem. Boil. 2008, 12, 72-77.
5. Haagensen, D. E. Jr., Kister, S. J., Panick, J., Giannola, J. et al., Comparative evaluation of carcinoembryonic antigen and gross cystic disease fluid protein as plasma markers for human breast carcinoma. Cancer 1978, 42, 1646-1652.
6. Suh, E. J., Kabir, M. H., Kang, U. B., Lee, J. W. et al., Comparative profiling of plasma proteome from breast cancer patients reveals thrombospondin-1 and BRWD3 as serological biomarkers. Exp. Mol. Med. 2012, 44, 36-44.
7. Fabre-Lafay, S., Garrido-Urbani, S., Reymond, N., Goncalves, A. et al., Nectin-4, a new serological breast cancer marker, is a substrate for tumor necrosis factor-α-converting enzyme (TACE)/ADAM-17. J. Biol. Chem. 2005, 280, 19543-19550.
8. Aka, J. A., Lin, S. X., Comparison of functional proteomic analyses of human breast cancer cell lines T47D and MCF7. PLoS One 2012, 7, e31532.
9. Geiger, T., Madden, S. F., Gallagher, W. M., Cox, J., Mann, M., Proteomic portrait of human breast cancer progression identifies novel prognostic markers. Cancer Res. 2012, 72, 2428-2439.
10. Chen, S. T., Pan, T. L., Juan, H. F., Chen, T. Y. et al., Breast tumor microenvironment: proteomics highlights the treatments targeting secretome. J. Proteome Res. 2008, 7, 1379-1387.
11. Bonin-Debs, A. L., Boche, L., Gille, H., Brinkmann, U., Development of secreted protein as biotherapeutic agents. Expert Opin. Biol. Ther. 2004, 4, 551-558.
12. Mbeunkui, F., Fodstad, O., Pannell, L. K., Secretory protein enrichment and analysis: an optimized approach applied on cancer cell lines using 2D LC-MS/MS. J. Proteome Res. 2006, 5, 899-906.
13. Mbeunkui, F., Metge, B. J., Shevde, L. A., Pannell, L. K., Identification of differently secreted biomarkers using LC-MS/MS in isogenic cell lines representing a progression of breast cancer. J. Proteome Res. 2007, 6, 2993-3002.
14. Clair, T., Miller, W. R., Cho-Chung, Y. S., Prognostic significance of the expression of a Ras protein with a molecular weight of 21, 000 by human breast cancer. Cancer Res. 1987, 47, 5290-5293.
15. Clark, G. J., Der, C. J., Aberrant function of the Ras signal transduction pathway in human breast cancer. Breast Cancer Res. Treat. 1995, 35, 133-144.
16. Prior, I. A., Hancock, J. F., Compartmentalization of Ras proteins. J. Cell Sci. 2001, 114, 1603-1608.
17. Moon, A., Kim, M. S., Kim, T. G., Kim, S. H. et al., H-ras, but not N-ras, induces an invasive phenotype in human breast epithelial cells: a role for MMP-2 in the H-ras-induced invasive phenotype. Int. J. Cancer 2000, 85, 176-181.
18. Kim, M. S., Lee, E. J., Kim, H. R., Moon, A., p38 kinase is a key signaling molecule for H-Ras-induced cell motility and invasive phenotype in human breast epithelial cells. Cancer Res. 2003, 63, 5454-5461.
19. Shin, I., Kim, S., Song, H., Kim, H. R., Moon, A., H-Ras-specific activation of Rac-MKK3/6-p38 pathway: its critical role in invasion and migration of breast epithelial cells. J. Biol. Chem. 2005, 280, 14675-14683.
20. Dowling, P., Clynes, M., Conditioned media from cell lines: a complementary model to clinical specimens for the discovery of disease-specific biomarkers. Proteomics 2011, 11, 794-804.
21. Xue, H., Lu, B., Lai, M., The cancer secretome: a reservoir of biomarkers. J. Transl. Med. 2008, 6, 52-63.
22. Choi, B. K., Cho, Y. M., Bae, S. H., Zoubaulis, C. C., Paik, Y. K., Single-step perfusion chromatography with a throughput potential for enhanced peptide detection by matrix-assisted laser desorption/ionization-mass spectrometry. Proteomics 2003, 3, 1955-1961.
23. Shen, T., Li, W., Wang, Y. Y., Zhong, Q. Q. et al., Antiproliferative activities of Garcinia bracteata extract and its active ingredient, isobractatin, against human tumor cell lines. Arch. Pharm. Res., 2013, doi: 10.1007/s12272-013-0196-1.
24. Ma, G., Greenwell-Wild, T., Lei, K., Jin, W. et al., Secretory leukocyte protease inhibitor binds to annexin II, a cofactor for macrophage HIV-1 infection. J. Exp. Med. 2004, 200, 1337-1346.
25. Cha, Y., Kang, Y., Moon, A., HER2 induces expression of leptin in human breast epithelial cells. BMB Rep. 2012, 45, 719-723.
26. Park, S. Y., Kim, H. S., Hong, E. K., Kim, W. H., Expression of cytokeratins 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas to the ovary. Hum. Pathol. 2002, 33, 1078-1085.
27. Zwickl, H., Traxler, E., Staettner, S., Parzefall, W. et al., A novel technique to specifically analyze the secretome of cells and tissues. Electrophoresis 2005, 26, 2779-2785.
28. Lennon, S. V., Martin, S. J., Cotter, T. G., Dose-dependent induction of apoptosis in human tumour cell lines by widely diverging stimuli. Cell Prolif. 1991, 24, 203-214.
29. Hayes, M. J., Shao, D., Bailly, M., Moss, S. E., Regulation of actin dynamics by annexin 2. EMBO J. 2006, 25, 1816-1826.
30. Bao, H., Jiang, M., Zhu, M., Zhu, M. et al., Overexpression of Annexin II affects the proliferation, apoptosis, invasion and production of proangiogenic factors in multiple myeloma. Int. J. Hematol. 2009, 90, 177-185.
31. Sharma, M., Ownbey, R. T., Sharma, M. C., Breast cancer cell surface annexin II induces cell migration and neoangiogenesis via tPA dependent plasmin generation. Exp. Mol. Pathol. 2010, 88, 278-286.
32. Zhao, S. H., Pan, D. Y., Zhang, Y., Wu, J. H. et al., Annexin A2 promotes choroidal neovascularization by increasing vascular endothelial growth factor expression in a rat model of argon laser coagulation-induced choroidal neovascularization. Chin. Med. J. (Engl) 2010, 123, 713-721.
33. Klausner, R. D., Donaldson, J. G., Lippincott-Schwartz, J., Brefeldin A: insights into the control of membrane traffic and organelle structure. J. Cell Biol. 1992, 116, 1071-1080.
34. Keller, M., Rüegg, A., Werner, S., Beer, H. D., Active caspase-1 is a regulator of unconventional protein secretion. Cell 2008, 132, 818-831.
35. Kraus, M. H., Yuasa, Y., Aaronson, S. A., A position 12-activated H-ras oncogene in all HS578T mammary carcinosarcoma cells but not normal mammary cells of the same patient. Proc. Natl. Acad. Sci. USA 1984, 81, 5384-5388.
36. Rajesh, D., Schell, K., Verma, A. K., Ras mutation, irrespective of cell type and p53 status, determines a cell's destiny to undergo apoptosis by okadaic acid, an inhibitor of protein phosphatase 1 and 2A. Mol. Pharmacol. 1999, 56, 515-525.
37. Hollestelle, A., Elstrodt, F., Nagel, J. H., Kallemeijn, W. W., Schutte, M., Phosphatidylinositol-3-OH kinase or RAS pathway mutations in human breast cancer cell lines. Mol. Cancer Res. 2007, 5, 195-201.
38. Rescher, U., Ludwig, C., Konietzko, V., Kharitonenkov, A., Gerke, V., Tyrosine phosphorylation of annexin A2 regulates Rho-mediated actin rearrangement and cell adhesion. J. Cell Sci. 2008, 121(Pt13), 2177-2185.
39. Goel, M., Sienkiewicz, A. E., Picciani, R., Lee, R. K., Bhattacharya, S. K., Cochlin induced TREK-1 co-expression and annexin A2 secretion: role in trabecular meshwork cell elongation and motility. PLoS One 2011, 6, e23070.
40. Kulasingam, V., Diamandis, E. P., Proteomics analysis of conditioned media from three breast cancer cell lines: a mine for biomarkers and therapeutic targets. Mol. Cell. Proteomics 2007, 6, 1997-2011.
41. Lai, T. C., Chou, H. C., Chen, Y. W., Lee, T. R. et al., Secretomic and proteomic analysis of potential breast cancer markers by two-dimensional differential gel electrophoresis. J. Proteome Res. 2010, 9, 1302-1322.
42. Moon, A., Yong, H. Y., Song, J. I., Cukovic, D. et al., Global gene expression profiling unveils S100A8/A9 as candidate markers in H-ras-mediated human breast epithelial cell invasion. Mol. Cancer Res. 2008, 6, 1544-1553.
43. Jaurand, M. C., Renier, A., Van der Meeren, A., Magne, L. et al., In vitro growth characteristics of rat mesothelioma cells in culture. Biol. Cell. 1986, 57, 249-256.
44. Vishwanatha, J. K., Chiang, Y., Kumble, K. D., Hollingsworth, M. A., Pour, P. M., Enhanced expression of annexin II in human pancreatic carcinoma cells and primary pancreatic cancers. Carcinogenesis 1993, 14, 2575-2579.
45. Sharma, M. R., Koltowski, L., Ownbey, R. T., Tuszynski, G. P., Sharma, M. C., Angiogenesis-associated protein annexin II in breast cancer: selective expression in invasive breast cancer and contribution to tumor invasion and progression. Exp. Mol. Pathol. 2006, 81, 146-156.
46. Mohammad, H. S., Kurokohchi, K., Yoneyama, H., Tokuda, M. et al., Annexin A2 expression and phosphorylation are up-regulated in hepatocellular carcinoma. Int. J. Oncol. 2008, 33, 1157-1163.
47. Ling, Q., Jacovina, A. T., Deora, A., Febbraio, M. et al., Annexin II regulates fibrin homeostasis and neoangiogenesis in vivo. J. Clin. Invest. 2004, 113, 38-48.
48. Zheng, L., Foley, K., Huang, L., Leubner, A. et al., Tyrosine 23 phosphorylation-dependent cell-surface localization of annexin A2 is required for invasion and metastases of pancreatic cancer. PLoS One 2011, 6, e19390.
49. Longerich, T., Haller, M. T., Mogler, C., Aulmann, S. et al., Annexin A2 as a differential diagnostic marker of hepatocellular tumors. Pathol. Res. Pract. 2011, 207, 8-14.
50. Zhang, Q., Ye, Z., Yang, Q., He, X. et al., Upregulated expression of annexin II is a prognostic marker for patients with gastric cancer. World J. Surg. Oncol. 2012, 10, 103-111.
51. Zhou, S., Yi, T., Liu, R., Bian, C. et al., Proteomics identification of annexin A2 as a key mediator in the metastasis and proangiogenesis of endometrial cells in human adenomyosis. Mol. Cell Proteomics 2012, 11, M112.017988-1-24.
52. Ji, N. Y., Park, M. Y., Kang, Y. H., Lee, C. I. et al., Evaluation of annexin II as a potential serum marker for hepatocellular carcinoma using a developed sandwich ELISA method. Int. J. Mol. Med. 2009, 24, 765-771.
53. Dassah, M., Deora, A. B., He, K., Hajjar, K. A., The endothelial cell annexin A2 system and vascular fibrinolysis. Gen. Physiol. Biophys. 2009, 28(SPEC), F20-F28.
54. Chasserot-Golaz, S., Vitale, N., Umbrecht-Jenck, E., Knight, D. et al., Annexin 2 promotes the formation of lipid microdomains required for calcium-regulated exocytosis of dense-core vesicles. Mol. Biol. Cell 2005, 16, 1108-1119.
55. Rousseau, S., Houle, F., Landry, J., Han, J., p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells. Oncogene 1997, 15, 2169-2177.
56. Matsumoto, T., Yokote, K., Tamura, K., Takemoto, M. et al., Platelet-derived growth factor activates p38 mitogen-activated protein kinase through a Ras-dependent pathway that is important for actin reorganization and cell migration. J. Biol. Chem. 1999, 274, 13954-13960.